Explore more publications!
North Dakota Technology Review
Got News to Share?

North Dakota Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Dakota Technology Review.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on December 23, 2025

Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease
December 23, 2025

Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease

Indeterminate GlobeNewswire
Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia
December 23, 2025

Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia

Indeterminate GlobeNewswire
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial
December 23, 2025

LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial

Indeterminate GlobeNewswire
Rezolve Ai Accelerates Global Momentum with Live Enterprise Deployments, Major Renewals and Expanding Pipeline into 2026
December 23, 2025

Rezolve Ai Accelerates Global Momentum with Live Enterprise Deployments, Major Renewals and Expanding Pipeline into 2026

Indeterminate GlobeNewswire
dLocal completes transition to a majority independent Board with appointments of Paco Ybarra and Nelson Mattos
December 23, 2025

dLocal completes transition to a majority independent Board with appointments of Paco Ybarra and Nelson Mattos

Indeterminate GlobeNewswire
Cassava Announces Agreement to Settle Securities Class Action Litigation
December 23, 2025

Cassava Announces Agreement to Settle Securities Class Action Litigation

Indeterminate GlobeNewswire
Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)
December 23, 2025

Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

Indeterminate GlobeNewswire
Renewal Fuels (RNWF) & Its Subsidiary American Fusion Highlight Near-Term Commercial Fusion Strategy, Underscoring Key Distinctions Between Deployable Energy Infrastructure & Experimental Fusion Programs
December 23, 2025

Renewal Fuels (RNWF) & Its Subsidiary American Fusion Highlight Near-Term Commercial Fusion Strategy, Underscoring Key Distinctions Between Deployable Energy Infrastructure & Experimental Fusion Programs

Indeterminate GlobeNewswire
Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6
December 23, 2025

Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6

Indeterminate GlobeNewswire
Surfshark is one of the few to add dedicated IP to the Linux GUI app
December 23, 2025

Surfshark is one of the few to add dedicated IP to the Linux GUI app

Indeterminate GlobeNewswire
Avicanna Announces Changes to its Board of Directors
December 23, 2025

Avicanna Announces Changes to its Board of Directors

Indeterminate GlobeNewswire
Dyne Therapeutics Appoints Vikram Karnani to Board of Directors
December 23, 2025

Dyne Therapeutics Appoints Vikram Karnani to Board of Directors

Indeterminate GlobeNewswire
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
December 23, 2025

Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

Indeterminate GlobeNewswire
Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
December 23, 2025

Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

Indeterminate GlobeNewswire
LAPIX Therapeutics Announces First Patient Dosed in Phase Ib Study of LPX-TI641 in Atopic Dermatitis
December 23, 2025

LAPIX Therapeutics Announces First Patient Dosed in Phase Ib Study of LPX-TI641 in Atopic Dermatitis

Indeterminate GlobeNewswire
Secura Bio Announces Participation in Gilmartin Group’s 2026 Corporate Access Event in San Francisco
December 23, 2025

Secura Bio Announces Participation in Gilmartin Group’s 2026 Corporate Access Event in San Francisco

Indeterminate GlobeNewswire
Red Cat Supports Administration’s Accelerated Enforcement of NDAA Section 1709, Highlights Need for U.S. Drone Ecosystem Investment
December 23, 2025

Red Cat Supports Administration’s Accelerated Enforcement of NDAA Section 1709, Highlights Need for U.S. Drone Ecosystem Investment

Indeterminate GlobeNewswire
AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)
December 23, 2025

AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)

Indeterminate GlobeNewswire
Aussie Casino starts using its own AI tool to test online casinos and understand player preferences
December 23, 2025

Aussie Casino starts using its own AI tool to test online casinos and understand player preferences

Indeterminate GlobeNewswire
Cityflee Introduces Stainless-Steel Litter Systems Designed Specifically for Multi-Cat Households
December 23, 2025

Cityflee Introduces Stainless-Steel Litter Systems Designed Specifically for Multi-Cat Households

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions